EUVIMEDEUVIMED entdecken
Crossref

MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR ‐T‐cell therapy

Hui Li iD, Youming Wang, Yingxiang Wang, Li Ding, Sujun Li, Miaomiao Wu, Qianwen Xu, Yuanli Chen iD, Xingbing Wang

British Journal of Haematology · 2026

DOI: 10.1111/bjh.70364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Hui Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Scien…. Hauptthemen laut MEDLINE: Macrophages, Macrophage Activation, Protein Kinase Inhibitors, Immunotherapy, Adoptive. Die Arbeit nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Key Research and Development Plan, Research project of Institute of Pioneer Medicine and Frontier Technology Project of the Hefei Comprehensive National Science Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesMacrophage ActivationProtein Kinase InhibitorsImmunotherapy, AdoptiveCytokine Release SyndromeReceptors, Chimeric AntigenMitogen-Activated Protein Kinase KinasesHumansLymphohistiocytosis, HemophagocyticCytokinesAnimals

Stichwörter der Autor:innen

CAR‐T therapyMEK inhibitorcytokine release syndromemacrophagesecondary haemophagocytic lymphohistiocytosis

Substanzen

Protein Kinase InhibitorsReceptors, Chimeric AntigenCytokinesMitogen-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • Department of Hematology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei…
  • National Key Laboratory of Immune Response and Immunotherapy, University of Science and Technology of China, Hefei, Anhui, China.
  • Anhui Provincial International Science and Technology Cooperation Base for Major Metabolic Diseases and Nutritional Interventions, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education…

ORCID-Profile: Hui Li, Yuanli Chen

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Key Research and Development Plan
  • Research project of Institute of Pioneer Medicine and Frontier Technology Project of the Hefei Comprehensive National Science Center

Zitieren

APA

Li, H., Wang, Y., Wang, Y., Ding, L., Li, S., Wu, M., Xu, Q., Chen, Y., & Wang, X. (2026). MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR ‐T‐cell therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.70364

Vancouver

Li H, Wang Y, Wang Y, Ding L, Li S, Wu M, et al. MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR ‐T‐cell therapy. British Journal of Haematology. 2026. doi:10.1111/bjh.70364

BibTeX
@article{Li2026,
  author = {Li, Hui and Wang, Youming and Wang, Yingxiang and Ding, Li and Li, Sujun and Wu, Miaomiao and Xu, Qianwen and Chen, Yuanli and Wang, Xingbing},
  title = {MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR ‐T‐cell therapy},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70364}
}
Kostenlos starten →